10.1002/asia.201900982
Chemistry - An Asian Journal
FULL PAPER
General
procedure
A
was
followed,
using
4-
133.1, 129.5, 128.8, 128.8, 128.6, 127.6, 127.2, 123.5, 122.3,
46.1, 45.2. [M+H]+ : calcd 350.1424, found 350.1430
nitrophenylisothiocyanate 3a (52.0 mg, 0.2886 mmol),
benzylamine (31.5 mg, 0.2886 mmol) and butylamine (31.6 mg,
0.4329 mmol). The compound was obtained in yellow solid
(0.0855 g, 94% yield.); 1H NMR (400 MHz, CDCl3) δ 8.06 (d, J =
7.6 Hz, 2H), 7.38-7.29 (m, 5H), 6.94 (d, J = 7.6 Hz, 2H), 4.41 (s,
2H), 3.14 (t, J = 7.2 Hz, 2H), 1.50-1.43 (m, 2H), 1.32-1.23 (m,
2H), 0.88 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 156.8,
152.5, 141.1, 138.1, 128.8, 127.7, 127.3, 125.5, 122.6, 46.1,
41.9, 31.5, 19.9, 13.6. [M+H]+ : calcd 327.1821, found 327.1849
1-butyl-3-cyclohexyl-2-phenylguanidine (5g)
General procedure A was followed, using phenylisothiocyanate
3a (50 mg, 0.3734 mmol), butylamine (27 mg, 0.3734 mmol) and
cyclohexylamine (55 mg, 0.5601 mmol) The compound was
obtained in yellow solid (0.0908 g, 89% yield.); 1H NMR (400
MHz, CDCl3) δ 7.17 (t, J = 7.6 Hz, 2H), 6.87 (t, J = 7.6 Hz, 1H),
6.81 (d, J = 7.6 Hz, 2H), 3.34-3.29 (m, 1H), 3.07 (t, J = 7.2 Hz,
2H), 1.92-1.89 (m, 2H), 1.68-0.93 (m, 12H), 0.85 (t, J = 7.2 Hz,
3H). 13C NMR (100 MHz, CDCl3) δ 151.2, 129.2, 123.5, 121.6,
50.4, 41.9, 33.7, 31.9, 25.6, 24.8, 20.1, 13.8. [M+H]+ : calcd
274.2283, found 274.2284
1-benzyl-3-butyl-2-(4-fluorophenyl)guanidine
General procedure was followed,
(5c)
A
using
4-
fluorophenylisothiocyanate 3a (51.0 mg, 0.3330 mmol),
benzylamine (36.0 mg, 0.3330 mmol) and butylamine (36.1 mg,
0.4995 mmol). The compound was obtained in colorless oil
1-benzyl-2,3-diphenylguanidine (5h)
General procedure A was followed, using phenylisothiocyanate
3a (50.5 mg, 0.3746 mmol), aniline (35.5 mg, 0.3746 mmol) and
benzylamine (60.1 mg, 0.5620 mmol) The compound was
obtained in yellow solid (0.1016 g, 90% yield.); 1H NMR (400
MHz, CDCl3) δ 7.23-7.12 (m, 9H), 6.94-6.90 (m, 6H), 4.38 (s,
2H). 13C NMR (100 MHz, CDCl3) δ 148.8, 138.8, 129.5, 128.7,
127.6, 127.4, 123.5, 123.0, 46.0. [M+H]+ : calcd 302.1657, found
302.1652.
1
(0.0917 g, 92% yield.); H NMR (400 MHz, CDCl3) δ 7.43-7.27
(m, 5H), 6.98 (t, J = 8.8 Hz, 2H), 6.84 (dd, J = 8.2, 5.2 Hz, 2H),
4.40 (s, 2H), 3.13 (t, J = 7.2 Hz, 2H), 1.54-1.37 (m, 2H), 1.35-
1.20 (m, 2H), 0.90 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3)
δ 158.4 (d, JC-F = 237.7 Hz), 151.7, 145.9, 138.9, 128.7, 127.5,
127.3, 124.6 (d, JC-F = 7.7 Hz), 115.9 (d, JC-F = 21.8 Hz), 46.0,
41.6, 31.8, 19.9, 13.7. [M+H]+ : calcd 300.1876, found 300.1893
1-benzyl-3-butyl-2-(p-tolyl)guanidine
General procedure was
(
5d
)
1-benzyl-3-(4-methoxyphenyl)-2-phenylguanidine (5i)
A
followed,
using
p-
General procedure A was followed, using phenylisothiocyanate
3a (50.8 mg, 0.3764 mmol), 4-methoxyphenylisothiocyanate
(46.1 mg, 0.3764 mmol) and benzylamine (60.3 mg, 0.5646
mmol) The compound was obtained in yellow solid (0.0973 g,
78% yield.); 1H NMR (400 MHz, CDCl3) δ 7.33-7.25 (m, 7H), 7.05
(d, J = 7.6 Hz, 3H), 7.01 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 8.8 Hz,
2H), 4.37 (s, 2H), 3.67 (s, 3H). 13C NMR (100 MHz, CDCl3) δ
156.9, 138.6, 129.4, 128.6, 127.6, 127.4, 125.6, 123.4, 123.2,
114.8, 55.4, 46.1. [M+H]+ : calcd 332.1763, found 332.1757.
tolylphenylisothiocyanate 3a (50.0 mg, 0.3351 mmol),
benzylamine (36.1 mg, 0.3351 mmol) and butylamine (37.3 mg,
0.5027 mmol). The compound was obtained in yellow oil (0.0881
1
g, 89% yield.); H NMR (400 MHz, CDCl3) δ 7.29-7.22 (m, 3H),
7.17 (m, 2H), 6.99 (d, J = 8.0 Hz, 2H), 6.73 (d, J = 8.0 Hz, 2H),
4.28 (s, 2H), 3.01 (t, J = 7.2 Hz, 2H), 2.20 (s, 3H), 1.40-1.28 (m,
2H), 1.21-1.11 (m, 2H), 0.78 (t, J = 7.2 Hz, 3H). 13C NMR (100
MHz, CDCl3) δ 151.6, 146.9, 139.1, 130.9, 129.9, 128.7, 127.4,
127.3, 123.3, 46.0, 41.6, 31.8, 20.7, 20.0, 13.7. [M+H]+ : calcd
296.2127, found 296.2150
1-benzyl-3-(4-methylpyridin-2-yl)-2-phenylguanidine (5j)
General procedure A was followed, using phenylisothiocyanate
3a (52.1 mg, 0.3854 mmol), 2-amino-4-metylpyridine (42.3 mg,
0.3854 mmol) and benzylamine (62.1 mg, 0.5782 mmol) The
compound was obtained in yellow solid (0.0841 g, 69% yield.);
1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 5.2 Hz, 1H), 7.27-7.06
(m, 8H), 6.88 (m, 2H), 6.39 (d, J = 5.2 Hz, 1H), 6.22 (s, 1H), 4.26
(s, 2H), 2.13 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 158.5, 151.3,
148.8, 147.6, 138.7, 129.4, 128.7, 127.4, 127.2, 123.5, 122.0,
115.5, 108.9, 46.0, 20.9. [M+H]+ : calcd 317.1766, found
316.1808
1-benzyl-3-butyl-2-(m-tolyl)guanidine
(5e)
General procedure was followed,
A
using
m-
tolylphenylisothiocyanate 3a (52.2 mg, 0.3497 mmol),
benzylamine (37.3 mg, 0.3497 mmol) and butylamine (38.1 mg,
0.5246 mmol). The compound was obtained in yellow oil (0.0940
1
g, 91% yield.); H NMR (400 MHz, CDCl3) δ 7.43-7.27 (m, 5H),
7.18 (t, J = 7.6 Hz, 1H), 6.85-6.70 (m, 3H), 4.39 (s, 2H), 3.12 (t,
J = 7.2 Hz, 2H), 2.32 (s, 3H), 1.49-1.42 (m, 2H), 1.33-1.23 (m,
2H), 0.90 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 151.8,
148.8, 139.0, 129.1, 128.7, 127.4, 127.3, 124.2, 122.7, 120.3,
46.1, 41.8, 31.8, 21.4, 19.9, 13.7. [M+H]+ : calcd 296.2127, found
296.2158
1-benzyl-3-(tert-butyl)-2-phenylguanidine (5k)
General procedure A was followed, using phenylisothiocyanate
3a (53.0 mg, 0.3921 mmol), t-butylamine (27.3 mg, 0.3921
mmol) and benzylamine (63.2 mg, 0.5881 mmol) The compound
was obtained in yellow solid (0.0993 g, 90% yield.); 1H NMR
(400 MHz, CDCl3) δ 7.42-7.26 (m, 7H), 6.98 (t, J = 7.2 Hz, 1H),
6.91 (d, J = 7.2 Hz, 2H), 4.41 (s, 2H), 1.31 (s, 9H). 13C NMR (100
MHz, CDCl3) δ 151.1, 139.1, 129.3, 128.7, 127.4, 127.4, 123.2,
1-benzyl-3-(4-chlorobenzyl)-2-phenylguanidine (5f)
General procedure A was followed, using phenylisothiocyanate
3a (50.9 mg, 0.3771 mmol), 4-chlorobenzylamine (53.2 mg,
0.3771 mmol) and benzylamine (60.9 mg, 0.5657 mmol). The
compound was obtained in yellow oil (0.0989 g, 75% yield.); 1H
NMR (400 MHz, CDCl3) δ 7.44-7.18 (m, 9H), 7.15 (d, J = 8.2 Hz,
2H), 7.02 (t, J = 7.2 Hz, 1H), 6.95 (d, J = 8.2 Hz, 2H), 4.34 (s,
4H). 13C NMR (100 MHz, CDCl3) δ 151.2, 148.6, 138.6, 137.4,
121.6, 50.9, 46.4, 30.1. [M+H]+
:
calcd 282.1970, found
282.1964.
1-benzyl-3-cyclohexyl-2-phenylguanidine
(5l)
For internal use, please do not delete. Submitted_Manuscript
This article is protected by copyright. All rights reserved.